Contribution: Industrial Research Assistance Program – Contributions to Firms
Canurta Inc.
$75,000.00
Artificial Intelligence for Design and Development of Novel Bioactive Flavonoids
FY 2022-23 · 2022-11-01
Summary
To build an effective computer-aided drug design pipeline to screen large libraries of bioactive compounds into smaller clusters of predicted active molecules that will present improved biological properties (bioavailability, efficacy and affinity for target proteins). It will focus on generating molecules that will be filtered on their calculated physiochemical properties to select the most drug-like analogs with structural similarity to existing cannflavins and exhibiting optimal ligand-target interactions. The predictive power of this platform accelerates the selection of promising lead compounds, provide insight into drug-receptor interactions and is beneficial in terms of cost savings, time-to-market and product portfolio expansion.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Mississauga|Mississauga, Ontario, Canada
Recipient Type
For-profit organization
Business Number
717319081
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2023-10-31
Agreement Number
997415
Agreement Start Date
2022-11-01
Agreement Title
Artificial Intelligence for Design and Development of Novel Bioactive Flavonoids
Agreement Title (French)
L’intelligence artificielle pour la conception et le développement de nouveaux flavonoïdes bioactifs
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
To build an effective computer-aided drug design pipeline to screen large libraries of bioactive compounds into smaller clusters of predicted active molecules that will present improved biological properties (bioavailability, efficacy and affinity for target proteins). It will focus on generating molecules that will be filtered on their calculated physiochemical properties to select the most drug-like analogs with structural similarity to existing cannflavins and exhibiting optimal ligand-target interactions. The predictive power of this platform accelerates the selection of promising lead compounds, provide insight into drug-receptor interactions and is beneficial in terms of cost savings, time-to-market and product portfolio expansion.
Description (French)
Construire un pipeline efficace de conception de médicaments assistée par ordinateur pour trier de grandes banques de composés bioactifs en petits groupes de molécules actives présumées qui présenteront des propriétés biologiques améliorées (biodisponibilité, efficacité et affinité vis-à-vis des protéines cibles). Elle se concentrera sur la génération de molécules qui seront filtrées en fonction de leurs propriétés physiochimiques calculées afin de sélectionner les analogues les plus proches des médicaments, présentant une similarité structurelle avec les cannflavines existantes et présentant des interactions ligand-cible optimales. Le pouvoir prédictif de cette plateforme permet d’accélérer la sélection de composés prometteurs, de mieux comprendre les interactions entre les médicaments et les récepteurs et est avantageux du point de vue de la réduction des coûts, du délai de mise sur le marché et de l’élargissement du portefeuille de produits.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Mississauga--Malton
Federal Riding (French)
Mississauga--Malton
Federal Riding Number
35062
NAICS Code
32519
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
717319081
Recipient City
Mississauga|Mississauga
Recipient Country
CA
Recipient Legal Name
Canurta Inc.
Recipient Operating Name
Canurta Inc.
Recipient Postal Code
L4W 5K4
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2022-2023-Q3-997415
